Table of Content

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Incidences of Skin Disorders
4.2.2 Technological Advancements in Skin Care Devices
4.2.3 Increasing Awareness on Aesthetic Procedures
4.3 Market Restraints
4.3.1 Side Effects Related To Dermatological Treatments
4.3.2 Stringent Regulatory Policies for Medical Devices
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Diagnostic Devices Type
5.1.1 Imaging Devices
5.1.2 Dermatoscopes
5.1.3 Microscopes
5.2 By Diagnostic Devices Application
5.2.1 Skin Cancer Diagnosis
5.2.2 Other Diagnostic Device Applications
5.3 By Treatment Devices Type
5.3.1 Light Therapy Devices
5.3.2 Lasers
5.3.3 Electrosurgical Equipment
5.3.4 Liposuction Devices
5.3.5 Microdermabrasion Devices
5.3.6 Cryotherapy Devices
5.4 By Treatment Devices Application
5.4.1 Vascular Lesions
5.4.2 Acne, Psoriasis, and Tattoo Removal
5.4.3 Hair Removal
5.4.4 Wrinkle Removal
5.4.5 Body Contouring and Fat Removal
5.4.6 Other Treatment Device Applications
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia Pacific
5.5.4 Middle East
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbvie Inc. (Allergan Inc.)
6.1.2 Alma Lasers Ltd
6.1.3 Bausch Health Companies Inc. (Solta Medical Inc.)
6.1.4 Bruker Corporation
6.1.5 CANDELA CORPORATION
6.1.6 Carl Zeiss
6.1.7 Cutera Inc.
6.1.8 Galderma SA
6.1.9 Genesis Biosystems Inc.
6.1.10 Hologic Inc. (Cynosure Inc.)
6.1.11 Lumenis Ltd
6.1.12 Merz Pharma GmbH & Co. KGaA


7 MARKET OPPORTUNITIES AND FUTURE TRENDS